GlassScriptPhysician profile
Thomas M Beaver
NPI 1043255607
$127,641.55
in general payments reported to CMS, 2019-2025
24 companies · $31K in 2025
The $31K reported for 2025 was more than what 95% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,416 · 2020: $1,907 · 2021: $9,369 · 2022: $1,682 · 2023: $28K · 2024: $53K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $59K · Travel and Lodging: $24K · Education: $15K · Food and Beverage: $6,143 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,175 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,512 · Gift: $77.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $58,721.00 |
| Travel and Lodging | $23,899.50 |
| Education | $14,740.00 |
| Food and Beverage | $6,142.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,175.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,512.00 |
| Gift | $77.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $39,268.41 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Edwards Lifesciences Corporation | $27,199.66 | 2020-2025 | Sapien 3 Ultra Resilia, Evoque, Inspiris Resilia Aortic Valve |
| Baxter Healthcare | $15,401.37 | 2024-2025 | Coseal, Hemopatch, Tisseel |
| Abbott Laboratories | $13,552.10 | 2021-2025 | Mitraclip, Triclip, Xience Sierra |
| W. L. Gore & Associates, INC. | $10,437.24 | 2019-2025 | Product In Development, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Conformable Thoracic Endoprosthesis |
| Merit Medical Systems INC | $7,249.67 | 2025 | |
| Medtronic, INC. | $6,285.19 | 2021-2025 | Advisa Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Evera Mri Xt Dr Surescan |
| Cook Incorporated | $3,500.00 | 2024 | Evolution |
| Medtronic Vascular, INC. | $1,217.15 | 2019-2020 | |
| Artivion, INC. | $1,154.98 | 2020-2025 | Cryovalve Sg Pulmonary Human Heart Valve |
| Jace Medical LLC | $875.00 | 2021 | |
| Cook Medical LLC | $311.29 | 2019-2025 | Cook |
| Bolton Medical INC | $272.15 | 2019-2025 | Treo Abdominal Stent-Graft System |
| Biosense Webster, INC. | $142.16 | 2024 | Carto 3 |
| Hemosonics LLC | $123.68 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $115.26 | 2023 | |
| Davol INC. | $111.33 | 2025 | |
| Admedus Corporation | $106.02 | 2019 | |
| La Jolla Pharmaceutical Company | $104.21 | 2021 | |
| Biomerieux INC | $89.44 | 2023 | |
| Abiomed | $77.54 | 2024 | Impella |
| Medistim USA, INC. | $33.33 | 2021 | |
| Lsi Solutions INC | $14.37 | 2025 | Cor-Knot |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Beaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.